The ongoing price disclosure system brokered by Medicines Australia and the Government will see another 13 medicines attract significant price cuts ranging from 11 to 77 per cent from August 1 this year. The medication price cuts are in addition to the broadbrush $1.9 billion in PBS savings that constitute the Memorandum of Understanding (MoU) [...]
The Government’s administration of the Pharmaceutical Benefits Scheme (PBS) is in the spotlight this month with a public inquiry into the deferral of medicines and possible repercussions for the pharmaceutical sector. Stakeholders have until next Friday, July 15, to submit their applications to The Finance and Public Administration References Committee for the public hearing, to [...]